Thymulin vs Thymalin
Comparing two similarly-named but different thymic peptides: thymulin (French FTS nonapeptide) versus thymalin (Russian polypeptide extract).
Last updated: February 1, 2026
Thymulin
Thymalin
Overview
Thymulin and Thymalin are often confused due to their similar names, but they are different compounds with distinct origins. Thymulin (FTS - Facteur Thymique Serique) is a defined 9-amino acid nonapeptide discovered by French researchers that requires zinc for activity. Thymalin is a Russian polypeptide extract from calf thymus containing multiple peptides. Understanding this distinction is important for researchers.
Key Facts
| Aspect | Thymulin | Thymalin |
|---|---|---|
| Also Known As | FTS, Serum Thymic Factor | Timalin, Thymic Factor |
| Origin | French (Bach laboratory) | Russian (Khavinson laboratory) |
| Structure | Defined nonapeptide | Polypeptide complex |
| Amino Acids | 9 | Multiple |
| Cofactor | Zinc required | None |
| FDA Status | Not approved | Not approved |
Name Confusion
| Issue | Clarification |
|---|---|
| Similar names | Thymulin =/= Thymalin |
| Different compounds | Completely different structures |
| Different origins | French vs Russian |
| Literature search | Must distinguish carefully |
Why the Confusion?
- Both from thymus research
- Similar time period (1970s)
- Both are thymic peptides
- Names differ by one letter
- Sometimes used interchangeably (incorrectly)
Discovery and Origin
| Aspect | Thymulin | Thymalin |
|---|---|---|
| Discovery | 1977 (France) | 1970s (USSR) |
| Discoverer | Jean-Francois Bach | Vladimir Khavinson |
| Institution | Hospital Necker, Paris | St. Petersburg Institute |
| Approach | Serum factor isolation | Tissue extraction |
Structure Comparison
| Aspect | Thymulin | Thymalin |
|---|---|---|
| Type | Defined peptide | Complex extract |
| Length | 9 amino acids | Multiple peptides |
| Sequence | Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn | EW, KE, EDP (components) |
| MW | 857 Da | ~10 kDa (range) |
| N-terminus | Pyroglutamic acid | Various |
| Zinc Binding | Essential | Not required |
Thymulin Structure Details
- Pyroglutamic acid N-terminus
- 9 amino acid sequence
- Must bind zinc for activity
- 1:1 zinc:peptide stoichiometry
- Inactive without zinc
Thymalin Composition
- Multiple peptides from thymus extract
- Active dipeptides: EW, KE
- Tripeptides: EDP
- Variable batch composition
- Standardization difficult
Zinc Requirement
| Factor | Thymulin | Thymalin |
|---|---|---|
| Zinc Essential | Yes | No |
| Activity Without Zn | None | Full |
| Zinc Binding Site | Specific | N/A |
| Clinical Implication | Zinc status matters | No zinc concern |
Thymulin Zinc Biology
| Aspect | Detail |
|---|---|
| Binding | Asp, Ser, and carbonyl groups |
| Ratio | 1 zinc per peptide |
| Reversible | Yes |
| Physiological | Serum zinc affects activity |
Mechanism Comparison
| Aspect | Thymulin | Thymalin |
|---|---|---|
| Primary Effect | T-cell differentiation | T-cell differentiation |
| Receptor | Unknown specific | Unknown/multiple |
| Zinc-Dependent | Yes | No |
| CNS Effects | Documented | Not primary |
Thymulin Mechanisms
-
T-Cell Development
- Supports thymocyte differentiation
- Pre-T cell maturation
- Thymic hormone function
-
Neuroimmune Axis
- Crosses blood-brain barrier
- Hypothalamic effects
- Stress-immune connections
- Well-documented CNS activity
-
Anti-Inflammatory
- Modulates cytokines
- Reduces inflammation
- Autoimmune model effects
Thymalin Mechanisms
-
T-Cell Differentiation
- HSC to mature T-cells
- CD marker modulation
- General immune restoration
-
Cytokine Modulation
- Pro-inflammatory suppression
- IL-1B, IL-6, TNF-a reduction
- NF-kB pathway involvement
Evidence Quality
| Factor | Thymulin | Thymalin |
|---|---|---|
| Western Research | Moderate | Minimal |
| Russian Research | Limited | Extensive |
| Human Trials | Few | Some (Russian) |
| Mechanism Studies | Moderate | Limited |
| Overall Evidence | Low | Low |
Thymulin Research
| Study Type | Availability |
|---|---|
| T-cell differentiation | In vitro studies |
| Zinc correlation | Human observational |
| Anti-inflammatory | Animal models |
| Neuroimmune | Animal studies |
Thymalin Research
| Study Type | Availability |
|---|---|
| Russian clinical | Multiple |
| Western validation | None |
| COVID-19 study | 1 observational |
| Longevity claims | Observational |
Regulatory Status
| Aspect | Thymulin | Thymalin |
|---|---|---|
| FDA | Not approved | Not approved |
| EMA | Not approved | Not approved |
| Russia | Not approved | Approved |
| Global | No approvals | Russia only |
Clinical Applications
Thymulin Research Applications
| Area | Evidence |
|---|---|
| Immune reconstitution | Preclinical |
| Aging research | Zinc connection |
| Neuroimmunology | Animal studies |
| Autoimmune | Preclinical |
Thymalin Clinical Uses (Russia)
| Indication | Approval |
|---|---|
| Immunodeficiency | Russian clinical |
| Post-infection | Russian clinical |
| Age-related decline | Russian clinical |
Administration
| Aspect | Thymulin | Thymalin |
|---|---|---|
| Route | Variable (research) | IM/SC injection |
| Zinc Consideration | Essential | None |
| Protocol | None standardized | 5-10 day courses |
Quality and Sourcing
Thymulin
| Factor | Status |
|---|---|
| Availability | Limited |
| Synthesis | Requires proper folding |
| Zinc | Must include for activity |
| Verification | Possible (defined) |
Thymalin
| Factor | Status |
|---|---|
| Availability | Research chemical |
| Standardization | Poor |
| Verification | Difficult (complex) |
| Bovine Origin | Theoretical concerns |
Which Do You Need?
| If Interested In | Consider |
|---|---|
| Zinc-dependent thymic biology | Thymulin |
| Neuroimmune research | Thymulin |
| Russian protocols | Thymalin |
| Defined compound | Thymulin |
| Clinical use precedent | Thymalin (Russian) |
Summary
| Factor | Thymulin | Thymalin |
|---|---|---|
| Origin | French (Bach) | Russian (Khavinson) |
| Structure | Defined nonapeptide | Polypeptide complex |
| Zinc Required | Yes (essential) | No |
| CNS Effects | Documented | Not primary |
| Regulatory | None | Russia only |
| Evidence Level | Moderate | Moderate |
| Availability | Limited | Research chemical |
Key Takeaways
- Different compounds: Despite similar names, these are distinct peptides
- Different origins: Thymulin is French; thymalin is Russian
- Structure differs: Thymulin is defined 9 AA; thymalin is complex extract
- Zinc requirement: Thymulin needs zinc for activity; thymalin does not
- Thymulin has CNS effects: Documented neuroimmune activity
- Thymalin has clinical use: Approved in Russia, not elsewhere
- Both lack Western approval: Neither recognized by FDA/EMA
- Name confusion common: Researchers must distinguish carefully
This comparison is for educational purposes only. Neither peptide is FDA-approved. Thymalin is approved in Russia. Both are research compounds in Western countries. Note: Despite similar names, these are completely different compounds.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.